"DRC Ebola News (11/15/19)." CSIS Commission on Strengthening America's Health Security, Center for Strategic and International Studies, November 15, 2019. Accessed June 12, 2020.

Daily update for November 15th, 2019 on the Ebola outbreak in eastern Democratic Republic of the Congo (DRC)

Photo Credit: Mike Stone/Getty Images

No new case was reported on November 15th.

Only 6 cases have been reported this week.

Médecins Sans Frontières (MSF) in collaboration with DRC’s Ministry of Health began administering the Johnson & Johnson (J&J) Ebola vaccine yesterday in Goma, as part of a large-scale clinical study.

Care for Ebola victims: Survivors help sick in DR Congo

DRC MoH Statistics/WHO AFRO Dashboard (as of November 15)

WHO AFRO Dashboard

Total cases: 3,292

  • Confirmed cases: 3,174
  • Probable cases: 118
  • Suspected cases: 527

Deaths: 2,194

Vaccinated: 251,079

Ebola virus disease – Democratic Republic of the Congo



All six cases resulted from local transmission in Beni and in Mabalako Health Zones in North Kivu, and all were known contacts of a confirmed case. While all cases can be linked to earlier transmission chains in Biakato Mines Health Area, Mandima Health Zone (Ituri), that health area has not reported a case since 4 November. As the number of cases decreases steadily, other case indicators appear to be encouraging. The proportion of registered contacts among cases prior to symptom onset is increasing over time, reaching 100% (6/6) in the past 7 days. Trends in proportion of community deaths among confirmed cases have also improved. A shorter delay from symptom onset to admission to isolation of alive EVD patients has also been reported. However, concerns remain around the recent shift of cases to Mabalako Health Zone. Ongoing local transmission in Bingo and Ngoyo Health Areas in Mabalako Health Zone is challenging because security issues have caused access and response difficulties in these areas.

MSF begins administering new Ebola vaccine in DRC



Approximately 23,000 doses of the J&J (Ad26.ZEBOV/MVA-BN) vaccine have arrived in the country. The study will result in more data on this second Ebola vaccine, which could pave the way for another approved tool to fight future Ebola epidemics. MSF community engagement teams have been meeting with people in Majengo and Kahembe health districts in Goma to share information about the vaccine and answer their questions. These two districts were identified in collaboration with health authorities as the first to be offered the vaccine. The vaccine will be offered to adults and to children aged one and older, and target 50,000 people over a four-month period.


Tweet by Helen Branswell– 11/15/19


3. The DRC daily #Ebola update mentions that there were people lined up yesterday in Goma to get the J&J vaccine on the first it was available. No indication of how many people were vaccinated yesterday.

Tweet by OMS RDC– 11/14/19


‏To efficiently provide treatment to people needing urgent medical care during epidemic situations, the @MinSanteRDC in the #DRC and the @WHO are this week training inaugural members of the country’s first national emergency medical units for epidemics.

Next Article